Anorectal Drugs Market
Number of pages: 100 | Report Format: PDF | Published date: June 02, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
CAGR |
7.25% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Indication, Drug Class, Distribution Channel, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global anorectal drugs market is expected to register a revenue CAGR of 7.25% from 2023 to 2031.
Anorectal Drugs Market Fundamentals
Anorectal drugs are medications that are used to treat various conditions affecting the anus and rectum. These medications can be found over the counter or prescribed by a healthcare professional, depending on the severity and nature of the treated condition. Anorectal diseases affect the region between the anus and the rectum. These problems can be caused by body structure, nutrition, lifestyle, and germs found in the body's waste. Drug categories for treating anorectal diseases include corticosteroids, local anesthetics, vasoconstrictors, and combination products containing multiple active ingredients.
Anorectal Drugs Market Dynamics
Anorectal disorders such as hemorrhoids, anal fissures, and anal itching are quite common, affecting a significant portion of the population. The rising prevalence of these conditions drives the demand for anorectal drugs as more individuals seek relief from their symptoms. For instance, according to the National Psoriasis Foundation statistics, 125 million people globally have psoriasis. There has been an increased awareness among individuals about anorectal disorders and their treatment options. This has guided more people to seek medical attention and diagnosis for their symptoms, resulting in fueling the demand for global anorectal drugs. Moreover, modern lifestyles characterized by sedentary behavior, lack of physical activity, and poor dietary habits contribute to the development of anorectal disorders. Factors such as obesity, inadequate fiber intake, and prolonged sitting can lead to constipation and increased pressure on the rectal area, increasing the demand for anorectal drugs. Furthermore, pharmaceutical companies continue to develop new and improved formulations of anorectal drugs. These formulations often offer enhanced efficacy, improved convenience, and reduced side effects, attracting both patients and healthcare professionals to utilize these products.
However, despite growing awareness, anorectal disorders are still associated with social stigma and embarrassment. Many individuals may feel uncomfortable discussing their symptoms or seeking medical help, leading to under diagnosis and undertreatment. This lack of awareness and stigma can restrain the market growth of anorectal drugs. Some anorectal drugs, especially those containing corticosteroids, can have side effects when used for prolonged periods or in high doses. These side effects may include skin thinning, increased blood pressure, or adrenal gland suppression. Safety concerns and potential adverse effects can impact patient confidence and limit the long-term use of certain anorectal drugs. Additionally, the availability of alternative treatments, side effects, and safety concerns are some of the restraints impeding the overall market growth.
Anorectal Drugs Market Ecosystem
The global anorectal drugs market is analyzed from four perspectives: indication, drug class, distribution channel, and region.
Anorectal Drugs Market by Indication
Based on the indication, the global anorectal drugs market is segmented into anal itching, condylomata acuminata, dermatological disorders, hemorrhoids, and psoriasis.
The hemorrhoids segment dominated the market with the principal revenue share in 2022, owing to its rising prevalence globally. For instance, according to the National Library of Biotechnology Information article of January 2022, the prevalence of hemorrhoidal disease was 16.6%, with females being more affected than males. Hemorrhoids are one of the most common anorectal disorders worldwide. The high prevalence of hemorrhoids creates a substantial market demand for medications to alleviate symptoms and treat the condition. Hemorrhoids are often associated with certain lifestyle and dietary factors such as prolonged sitting, low-fiber diets, obesity, and constipation. These factors are becoming increasingly prevalent due to modern sedentary lifestyles. These aspects contribute to the growth of the hemorrhoids segment.
Anorectal Drugs Market by Drug Class
Based on the drug class, the global anorectal drugs market is segmented into corticosteroids, anti-infectives, local anesthetics, vasoconstrictors, and others.
The anti-infectives segment accounted for a prominent share of the market. Anti-infectives are essential for treating anorectal infections, including bacterial, viral, and fungal infections. These infections can cause symptoms such as pain, inflammation, itching, discharge, and discomfort. Anti-infective drugs specifically target the underlying infectious agents, helping to eliminate the infection and alleviate associated symptoms. Anti-infectives used in the anorectal drugs market often have a broad spectrum of action, meaning they can effectively target various types of microorganisms, including bacteria, viruses, and fungi. This versatility allows for treating different types of anorectal infections, regardless of the specific infectious agent involved. These factors contribute to the growth of the orthopedic surgery segment.
The local anesthetics segment accounted for a prominent share of the market. Local anesthetics are crucial in providing pain relief during various anorectal procedures and conditions. They are commonly used to provide pain relief during anorectal procedures such as hemorrhoidectomy, anal fissure surgery, or abscess drainage. Local anesthetics numb the region by blocking nerve impulses in the targeted area, allowing the procedure to be performed with minimal discomfort for the patient. Local anesthetics in the form of creams, ointments, or sprays are used to provide temporary relief from pain and discomfort associated with these conditions. Local anesthetics offer the advantage of providing targeted pain relief without the need for general anesthesia in certain anorectal procedures. This can be particularly beneficial for patients who may not be suitable candidates for general anesthesia due to underlying health conditions or personal preferences. These factors contribute to the growth of the local anesthetics segment.
Anorectal Drugs Market by Distribution Channel
Based on the distribution channel, the global anorectal drugs market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies.
The hospital pharmacies segment is a key player in the anorectal drugs market with the largest revenue share in 2022, owing to the high footfall. Hospital pharmacies are responsible for ensuring the availability and timely dispensing of medications to patients within the hospital setting. This includes anorectal drugs prescribed for conditions such as hemorrhoids, anal fissures, or post-operative care. Hospital pharmacies play a vital role in meeting the immediate medication needs of patients, driving the demand for anorectal drugs. Hospital pharmacies collaborate closely with healthcare professionals, including doctors, surgeons, and nurses, to provide optimal pharmaceutical care. They work together to determine the appropriate anorectal drugs for specific patient needs, considering factors such as the severity of the condition, patient medical history, and drug interactions. Hospital pharmacies often have the capacity to dispense and compound medications on-site. This is particularly relevant for anorectal drugs, as some may require specific formulations or customized dosages.
Anorectal Drugs Market by Region
Geographically, the global anorectal drugs market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America dominated the global anorectal drugs market with the largest revenue share in 2022, attributed to the high prevalence of anorectal disorders, technological advancements and innovation, and the strong presence of pharmaceutical companies. North America is known for its advanced healthcare infrastructure, including hospitals, clinics, and pharmaceutical industries. The region has well-established healthcare systems that provide access to quality healthcare services. This infrastructure supports the developing, manufacturing, and distributing of anorectal drugs, ensuring their availability to patients in need. Additionally, companies across the region are continuously involved in partnerships, mergers, and acquisitions, which are also expected to improve the anorectal drugs market outlook.
Anorectal Drugs Market Competitive Landscape
The prominent players operating in the global anorectal drugs market are:
Anorectal Drugs Market Strategic Developments
Anorectal drugs are medications that are used to treat various conditions affecting the anus and rectum.
The revenue CAGR of the anorectal drugs market during the forecast period will be 7.25% from 2023 to 2031.
Some key companies operating in the global anorectal drugs market arePerrigo Company plc, Takeda Pharmaceutical Company Limited., GSK plc, Sanofi SA, and Teva Pharmaceutical Industries Ltd.
Availability of alternative treatments and side effects & safety concerns are restricting the global market growth to full potential.
The increasing prevalence of anorectal disorders, rowing awareness, improved diagnosis, and advancements in drug formulations are the factors driving the market growth.
*Insights on financial performance are subject to the availability of information in the public domain